These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 27168844)

  • 21. DL-3-n-butylphthalide for acute ischemic stroke: An updated systematic review and meta-analysis of randomized controlled trials.
    Wang H; Ye K; Li D; Liu Y; Wang D
    Front Pharmacol; 2022; 13():963118. PubMed ID: 36120291
    [No Abstract]   [Full Text] [Related]  

  • 22. Cerebrolysin for functional recovery in patients with acute ischemic stroke: a meta-analysis of randomized controlled trials.
    Wang Z; Shi L; Xu S; Zhang J
    Drug Des Devel Ther; 2017; 11():1273-1282. PubMed ID: 28458521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and Safety of Cerebrolysin for Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled Trials.
    Zhang D; Dong Y; Li Y; Chen J; Wang J; Hou L
    Biomed Res Int; 2017; 2017():4191670. PubMed ID: 28656143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroprotective treatment with cerebrolysin in patients with acute stroke: a randomised controlled trial.
    Ladurner G; Kalvach P; Moessler H;
    J Neural Transm (Vienna); 2005 Mar; 112(3):415-28. PubMed ID: 15583955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of Cerebrolysin treatment in early recovery after acute ischemic stroke: a randomized, placebo-controlled, double-blinded, multicenter clinical trial.
    Gharagozli K; Harandi AA; Houshmand S; Akbari N; Muresanu DF; Vester J; Winter S; Moessler H
    J Med Life; 2017; 10(3):153-160. PubMed ID: 29075343
    [No Abstract]   [Full Text] [Related]  

  • 26. N-Butylphthalide vs. Human Urinary Kallidinogenase for the Treatment of Acute Ischemic Stroke: Functional Outcome and Impact on Serum VEGF and TNF-α Expressions.
    Guo Y; Abdoulaye IA; Liu F; Wang J; Tian X; Yu D; Le K
    Ann Clin Lab Sci; 2021 Jul; 51(4):503-511. PubMed ID: 34452888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial.
    Hess DC; Wechsler LR; Clark WM; Savitz SI; Ford GA; Chiu D; Yavagal DR; Uchino K; Liebeskind DS; Auchus AP; Sen S; Sila CA; Vest JD; Mays RW
    Lancet Neurol; 2017 May; 16(5):360-368. PubMed ID: 28320635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and efficacy of GABA
    Chabriat H; Bassetti CL; Marx U; Audoli-Inthavong ML; Sors A; Lambert E; Wattez M; Hermann DM;
    Lancet Neurol; 2020 Mar; 19(3):226-233. PubMed ID: 32085836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of butylphthalide on new cerebral microbleeds in patients with acute ischemic stroke.
    Ding Y; Gu Z; Zhai T; Wang W; Zhang Y; Wei C; Liu Y; Niu J
    Medicine (Baltimore); 2020 Aug; 99(32):e21594. PubMed ID: 32769914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of Cerebrolysin in motor function recovery after stroke: a meta-analysis of the CARS trials.
    Guekht A; Vester J; Heiss WD; Gusev E; Hoemberg V; Rahlfs VW; Bajenaru O; Popescu BO; Doppler E; Winter S; Moessler H; Muresanu D
    Neurol Sci; 2017 Oct; 38(10):1761-1769. PubMed ID: 28707130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebrolysin adjuvant treatment in Broca's aphasics following first acute ischemic stroke of the left middle cerebral artery.
    Jianu DC; Muresanu DF; Bajenaru O; Popescu BO; Deme SM; Moessler H; Meinzingen SZ; Petrica L
    J Med Life; 2010; 3(3):297-307. PubMed ID: 20945821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of DL-3-n-butylphthalide in patients with vascular cognitive impairment without dementia caused by subcortical ischemic small vessel disease: A multicentre, randomized, double-blind, placebo-controlled trial.
    Jia J; Wei C; Liang J; Zhou A; Zuo X; Song H; Wu L; Chen X; Chen S; Zhang J; Wu J; Wang K; Chu L; Peng D; Lv P; Guo H; Niu X; Chen Y; Dong W; Han X; Fang B; Peng M; Li D; Jia Q; Huang L
    Alzheimers Dement; 2016 Feb; 12(2):89-99. PubMed ID: 26086183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Results of the multicenter prospective study of cerebrolysin safety and efficacy in acute stroke].
    Skwortsova VI; Stakhovskaia LV; Shamalov NA; Kerbikov OB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; Suppl 16():41-5. PubMed ID: 18196634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and Safety of
    Feng L; Han F; Zhou L; Wu S; Du Y; Zhang D; Zhang C; Gao Y
    Front Pharmacol; 2021; 12():648921. PubMed ID: 33967788
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of dl-3-n-butylphthalide on serum lipoprotein-associated phospholipase A2 and hypersensitive C-reactive protein levels in acute cerebral infarction.
    Zhang XL; Dong YT; Liu Y; Zhang Y; Li TT; Hu FY
    Brain Behav; 2019 Dec; 9(12):e01469. PubMed ID: 31724337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of Cerebrolysin in patients with hemorrhagic stroke.
    Bajenaru O; Tiu C; Moessler H; Antochi F; Muresanu D; Popescu BO; Novak P
    J Med Life; 2010; 3(2):137-43. PubMed ID: 20968198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DL-3-n-butylphthalide improves cerebral hypoperfusion in patients with large cerebral atherosclerotic stenosis: a single-center, randomized, double-blind, placebo-controlled study.
    Chen D; Yin Y; Shi J; Yang F; Wang K; Zhao F; Li W; Li B
    BMC Neurol; 2020 May; 20(1):212. PubMed ID: 32456617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebrolysin dose-dependently improves neurological outcome in rats after acute stroke: A prospective, randomized, blinded, and placebo-controlled study.
    Zhang L; Chopp M; Lu M; Zhang T; Winter S; Doppler E; Meier D; Chao L; Eapen A; Pabla P; Gang Zhang Z
    Int J Stroke; 2016 Apr; 11(3):347-55. PubMed ID: 26763925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial.
    Muresanu DF; Heiss WD; Hoemberg V; Bajenaru O; Popescu CD; Vester JC; Rahlfs VW; Doppler E; Meier D; Moessler H; Guekht A
    Stroke; 2016 Jan; 47(1):151-9. PubMed ID: 26564102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial.
    Elkins J; Veltkamp R; Montaner J; Johnston SC; Singhal AB; Becker K; Lansberg MG; Tang W; Chang I; Muralidharan K; Gheuens S; Mehta L; Elkind MSV
    Lancet Neurol; 2017 Mar; 16(3):217-226. PubMed ID: 28229893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.